Navigation Links
China Medicine Corporation to Present at Brean Murray Carret & Co. Mainland China Investor Tour
Date:3/31/2008

GUANGZHOU, China, March 31 /Xinhua-PRNewswire/ -- China Medicine Corporation (OTC Bulletin Board: CHME; "China Medicine" or "the Company"), a leading distributor and developer of prescription and over-the-counter pharmaceuticals, traditional Chinese medicines (TCM), nutritional and dietary supplements, medical devices, and medical formulations in the PRC, today announced that the Company will present at the upcoming Brean Murray Carret & Co. Mainland China Investor Tour of China on Thursday April 3, 2008 at Marco Polo Hotel in Shenzhen, China.

Mr. Yang Senshan, China Medicine's Chairman and CEO, will present the overview of the Company's main business, product lines, facilities, competitive strengths, and growth strategies at 9:45 am local time.

For more information about the conference, please visit http://www.breanmurraycarret.com .

About China Medicine Corporation

China Medicine Corporation is a leading pharmaceutical company which discovers and develops medical formulations and distributes over 2,200 pharmaceutical products in China including prescription and over-the-counter ("OTC") drugs, traditional Chinese medicine products, herbs and dietary supplements. The Company distributes the products to wholesale distributors in 28 provinces, more than 300 hospitals, 500 medicine companies, and 1,788 drug stores throughout China. The Company actively develops a number of proprietary products for many uses including oncology, high blood pressure and the removal of toxins from food and animal feeds. For more information visit the Company's website at http://www.chinamedicinecorp.com .

Cautionary Statement

This press release contains forward-looking statements concerning the Company's business and products. The Company's actual results may differ materially depending on a number of risk factors including, but not limited to, the following: general economic and business conditions, obtaining regulatory approval for new products, the expected contribution of higher margin products, government support for rural health care, competition from existing and new competitors, changes in technology, and various other factors beyond its control. All forward-looking statements are expressly qualified in their entirety by this Cautionary Statement and the risk factors detailed in the Company's reports filed with the Securities and Exchange Commission. China Medicine Corporation undertakes no duty to revise or update any forward- looking statements to reflect events or circumstances after the date of this release.

For more information, please contact:

CCG Elite Investor Relations Inc.

Mr. Crocker Coulson, President

Tel: +1-646-213-1915 (New York)

Email: crocker.coulson@ccgir.com

China Medicine Corp

Ms. Huizhen Yu, CFO

Tel: +86-20-8739-1718

Email: konzern08@168.com


'/>"/>
SOURCE China Medicine Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. China Yingxia International, Inc. Announces Record Fourth Quarter and Year 2007 Results
2. China Yingxia International Announces Soybean Milk Production Lines Acquisition
3. Cells from the Research Institute of the MUHC on the road to China
4. China Medicine Announces Record Fourth Quarter and Fiscal Year 2007 Results
5. China Yingxia International Announces 2007 Fourth Quarter and Full Year Financial Results Conference Call
6. China Medicine Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2007 Results
7. China RuiTai International Holdings Retains CCG Elite for Investor Relations Services
8. China Medical Technologies Receives CE Mark for Two ECLIA Analyzers and 15 Reagents
9. Sinovac to Present at the Brean Murray, Carret & Co. Fourth Investor Tour of China
10. China Nepstar Chain Drugstore Announces Dividend
11. Alsius Corporation Receives Regulatory Approval in China and Mexico
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... , ... July 21, 2017 , ... West Dermatology is ... Doan Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large ... of experience in dermatology, skin cancer , and more. She graduated from the ...
(Date:7/21/2017)... ... July 21, 2017 , ... ... concussion rates are on the rise, say researchers presenting their work at the ... Ontario, Canada. , “The combination of evaluating the patterns of change in concussion ...
(Date:7/20/2017)... ... 20, 2017 , ... Acute myeloid leukemia (AML) is a ... without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem cell ... With such a challenging diagnosis that requires immediate action, patients and caregivers need ...
(Date:7/20/2017)... ... July 20, 2017 , ... For individuals with extended hospital stays or ... used in such facilities are specially designed to accommodate patients with a wide range ... An inventor from Rochester, Ind., has invented the patent-pending PORTABLE ARM REST, a specially ...
(Date:7/20/2017)... ... July 20, 2017 , ... Doctors on Liens, the leading network ... Horine Chiropractic , directed by Dr. Russell Horine, DC to their exclusive list of ... with Dr. Russell Horine serving as the clinic director and his son Dr. Lee ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... CarpalAID is a revolutionary new product that relieves painful carpal tunnel ... syndrome affects more than 8 million people a year. Women suffer ... common methods of treating CTS are painful surgery, the use of ... ... is a clear patch worn on the palm of the hand. ...
(Date:7/11/2017)... Research Corp., also known as ,The Epigenetics Company, announced today the release ... manner using the myDNAge ™ test. Based on Horvath,s Clock, so ... and biostatistics at the David Geffen School of Medicine at UCLA ... DNAge ™ technology is used to analyze DNA methylation patterns of ... ...
(Date:7/11/2017)... Md. , July 11, 2017  The global ... estimated revenues of approximately $394.1 million in 2016.  Although ... trend of solid growth, in particular as a result ... clinical practice, and the recent introduction of a significant ... need for less-invasive testing of tumor biomarkers to guide ...
Breaking Medicine Technology: